Nanobac Pharmaceuticals, Incorporated

NNBP · OTC
Analyze with AI
12/31/2007
12/31/2006
12/31/2005
12/31/2004
Assets
Cash & Equivalents$4$40$9$18
Short-Term Investments$0$0$0$0
Receivables$2$1$3$3
Inventory$10$66$117$71
Other Curr. Assets$15$20$44$24
Total Curr. Assets$31$127$173$116
Property Plant & Equip (Net)$38$60$107$125
Goodwill$3,615$3,615$3,615$0
Intangibles$3,527$3,964$5,053$9,376
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$9$59$21$68
Total NC Assets$7,189$7,698$8,796$9,569
Other Assets$0$0$0$0
Total Assets$7,220$7,825$8,970$9,684
Liabilities
Payables$1,078$409$314$645
Short-Term Debt$4,122$5,367$2,486$256
Tax Payable$0$0$0$0
Deferred Revenue$1,536$0$840$386
Other Curr. Liab.$1,545$524$869$403
Total Curr. Liab.$6,745$6,300$3,668$1,305
LT Debt$962$962$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,875$1,875$2,837$2,269
Total NC Liab.$2,837$2,837$2,837$2,269
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$9,582$9,136$6,505$3,573
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$16,307$16,297
Retained Earnings-$28,930-$2,235-$17,381-$13,050
AOCI-$105-$21$35-$675
Other Equity$26,673$21,063$19,811$4,183
Total Equity-$2,362-$1,312$2,465$6,111
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$7,220$7,825$8,970$9,684
Net Debt$5,080$6,289$2,477$239
Nanobac Pharmaceuticals, Incorporated (NNBP) Financial Statements & Key Stats | AlphaPilot